- Home
- WBX vs CLNN Comparison
WBX vs CLNN Comparison
Compare WBX & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WBX | CLNN |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 120.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WBX | CLNN |
|---|---|---|
| Price | $2.37 | $5.67 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 6 |
| Target Price | $9.00 | ★ $32.67 |
| AVG Volume (30 Days) | 33.3K | ★ 313.2K |
| Earning Date | 02-26-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $174,593,453.00 | $214,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.11 | $92.84 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.30 | $2.28 |
| 52 Week High | $14.40 | $13.50 |
Technical Indicators
Market Signals| Indicator | WBX | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 25.90 | 38.22 |
| Support Level | $2.30 | $5.62 |
| Resistance Level | $3.36 | $6.27 |
| Average True Range (ATR) | 0.20 | 0.52 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 6.60 | 20.13 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.